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Abstract
Introduction: Primary osteosarcoma of the breast is a rare malignant tumour. It is typically a poor
prognosis tumour, which has some interesting features worthy of discussion. We report a case of
primary osteosarcoma of the breast and summarise the previous medical literature to highlight
several details of this unusual tumour.
Case presentation: A 66-year-old Caucasian lady presented with painless lump in her right
breast. Mammography showed features of fibroadenoma with calcification and fine needle
aspiration cytology was reported as showing malignant cells (C5). Wide local excision was
performed and histological features were consistent with primary osteosarcoma with
predominance of osteoclastic activity. Subsequent completion mastectomy was performed because
of suspicion of incomplete excision. She remains disease free 8 years from her initial surgery.
Introduction
Extra-osseous osteogenic sarcomas have been reported
from the thyroid gland, kidney, bladder and soft tissues,
but mammary osteogenic sarcomas constitute only a
small group [1]. Primary sarcomas of the breast are
extremely rare and make up less than 0.1% of all malig-
nant tumours of the breast [2]. Fewer than 150 cases of
primary osteosarcoma of breast have been reported in the
medical literature in the last 50 years. When this tumour
develops in the breast, it originates either from normal
breast tissue de novo, or as metaplastic differentiation of a
primary benign or malignant breast lesion. Secondary
deposits from a primary bone sarcoma occur only rarely.
Primary osteogenic breast cancer is usually considered a
poor prognosis tumour, with high risk of disease recur-
rence and haematogeneous spread, most commonly to
the lungs.
We present the case of a 66 year old Caucasian woman
who was diagnosed with an osteogenic sarcoma of the
breast and has survived eight years from surgical resection.
We have performed a thorough literature review and
would like to use this case to highlight several details of
this unusual tumour.
Case presentation
A 66-year-old Caucasian lady presented with a painless,
enlarging lump in her right breast. There was no history of
trauma, skin changes, nipple discharge, or any other
breast lumps. She was otherwise asymptomatic with no
symptoms of bone pain. There was no family history of
breast cancer. She had a past medical history of severe
chronic obstructive airways disease, previous fracture neck
of femur and surgery for a hiatus hernia. There was no
prior history of radiotherapy. Clinical examination
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revealed a non-tender hard lump in right upper quadrant
with no palpable axillary lymph nodes. Mammography
showed features of fibroadenoma with calcification. Fine
needle aspiration cytology (FNAC) was positive for malig-
nant cells (C5).
Wide local excision of the breast lump was performed in
August 1998. This was performed under local anaesthesia
due to her poor respiratory function. Macroscopic exami-
nation of the excised specimen revealed it to be composed
of a piece of fibrofatty tissue measuring 6 × 4 × 2 cm that
weighed 33 grams. There was a 2 cm cystic mass contain-
ing a necrotic tumour. The tumour appeared to infiltrate
the cyst wall and extended to within 3 mm from the near-
est resection margin. Microscopically, an encapsulated
tumour composed of spindle cells, osteoclastic giant cells
and osteoblasts was found. The spindle cells contained
plump nuclei with prominent nucleoli. The cytoplasm
was pale to eosinophilic with indistinct cell border. The
tumour showed high apoptotic activity that was mitoti-
cally active with 24 mitoses/10 high power field. The
tumour demonstrated osteoclastic and osteoblastic activ-
ity with marked osteoid formation (Figure 1). Immuno-
histochemistry was performed and the tumour cells were
positive for vimentin. MNF116 and CAM5.2 (which are
broad spectrum cytokeratin epithelial markers) staining
was negative proving this was a primary osteosarcoma
rather than metaplastic breast sarcoma (Figure 1). The
tumour was also negative for S100, desmin and smooth
muscle actin. The tumour infiltrated the breast capsule
and extended very close to the resection margins, there-
fore it was not possible to be certain that excision was
complete and further excision was advised.
Computer tomography of the thorax and abdomen
showed no evidence of distant metastasis. The patient was
optimised for general anaesthesia after consultation with
a Consultant Respiratory Physician who managed to
improve her respiratory function with medical therapy.
Subsequent right sided mastectomy was performed under
general anaesthesia in January 1999. As the spread of
extraskeletal osteosarcoma is haematogenous rather via
lymph, axillary lymphadenectomy was not perfomed.
Histology of the mastectomy specimen showed no evi-
dence of residual tumour involvement.
She was followed up in the outpatient clinic every 6
months. In March 2001, a magnetic resonance imaging
(MRI) scan of right axilla was performed for a clinical sus-
picion of an axillary lump, but this was found to be nor-
mal. She was last reviewed in the breast clinic in
November 2006 and was found to have no clinical evi-
dence of recurrent disease and was therefore discharged
back to the care of her General Practitioner.
Discussion
Extra-skeletal sarcomas tend to occur in the over 50 year
old age group [3], which is in contrast to osteogenic sar-
coma arising from bone which mainly occur in children
and adolescents. Primary osteosarcomas of the breast are
very rare and account for less than 0.1% of breast tumours
[2] and are often found in women with a mean age of 64
years [4].
The carcinogenesis of primary osteogenic sarcoma of the
breast is not clear, but an origin from totipotent mesen-
chymal cells of the breast stroma or a transformation from
a pre-existing breast lesion has been suggested. For exam-
ple, the tumour may originate from either benign breast
neoplasms, such as a long standing fibroadenoma or an
intraductal papilloma; or a malignant breast lesion, such
as a phyllodes tumour [5]. To confirm the diagnosis of
primary osteogenic sarcoma of the breast, the direct exten-
sion of an osteogenic sarcoma arising from the ribs or ster-
num should be excluded. Primary breast carcinoma with
extensive osseous metaplasia must also be considered [6].
Preoperative diagnosis is unusual and most patients the
correct histological diagnosis of only established after sur-
gical resection[7]. The mammographic appearances of
these tumours are of a well circumscribed dense lesion
within the breast tissue with focal or extensive coarse cal-
cifications [8]. The border may be regular or irregular. The
mammographic appearances may be deceptively benign
and may imitate a benign fibroadenoma in a third of cases
[4]. Fine needle aspiration cytology may not yield some
clues to the diagnosis with features such as hypocellular or
hypercellular smears with pleomorphic cells; scarce or
abundant metachromatic amorphous material, suggestive
of osteoid; osteoclast-like giant cells; and stromal frag-
ments [9].
The main histological differential diagnosis in our case
was metaplastic carcinoma [2], however this was excluded
because of negative epithelial markers on immunohisto-
chemical staining. Metaplastic carcinoma is recognised
either by the presence of carcinomatous compenent on
H&E staining or by cytokeratin immunoreactivity of the
neoplastic spindle cells [2]. Phyllodes tumour was not a
differential diagnosis in our case, but would be it in any
sarcoma with a predominantly fibroblastic component.
However, our case had characteristic osteoid formation
and osteoclastic giant cells and it is possible to say with
conclusively that our case is an osteosarcoma (Figure 1).
Surgical management of these tumours is either by wide
local excision or mastectomy depending on the size of the
tumour and remaining breast tissue. It is important to
achieve a complete resection with negative resection mar-
gins, as margin status is a major factor for local diseaseCases Journal 2008, 1:148 http://www.casesjournal.com/content/1/1/148
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(a) Osteosarcoma (×4); (b) Giant cells with osteoid formation (×20); (c) Giant cells with osteoid formation (×20); (d) Negative  immunohistochemical staining for CAM5 Figure 1
(a) Osteosarcoma (×4); (b) Giant cells with osteoid formation (×20); (c) Giant cells with osteoid formation (×20); (d) Negative 
immunohistochemical staining for CAM5.2 (×20); (e) Negative immunohistochemical staining for MNF116 (×20); (f) Positive 
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recurrence. Axillary clearance is not necessary as these
tumours do not spread via the lymphatic route. Adjuvant
radiotherapy to the chest wall may reduced the risk of
local recurrence [10]. Although adjuvant chemotherapy
with either doxorubicin, cisplatin or ifosfamide based
regimes has increased the survival of primary bone sarco-
mas, there are no proven benefits to the use of these
regimes in primary osteosarcoma of the breast.
The long-term prognosis is uncertain due to the small
number of cases reported in the medical literature. Silver
et al reported a 5 year survival of 38% in a study of 50
patients with primary breast oestosarcoma [4]. Twenty
eight percent of patients developed local recurrence and
41% distant metastases. Haematogenous metastases most
commonly occur to the lungs (80%), bone (20%), and
liver (17%). Prognostic factors included tumour size,
number of mitoses, presence of stromal atypia, histologi-
cal subtype and resection margin involvement [4].
The learning points from our case are presented in Table
1.
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Table 1: Learning points from this case report
Learning points
1. Primary breast sarcomas are rare tumours of the breast. They make up less than 0.1% of all breast tumours.
2. Tumour development is either from normal breast tissue de novo, or as metaplastic differentiation of a primary benign or malignant breast 
lesion. Secondary deposits from a primary bone sarcoma occur only rarely, but need to be
3. excluded clinically. Diagnosis is made by careful assessment of the histological specimen, together with immunohistochemical staining.
4. Typically primary osteogenic breast cancer is usually considered a poor prognosis tumour, with high risk of disease recurrence and 
haematogeneous spread, most commonly to the lungs. Lymph node metastases do not occur.